Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179556 · ClinicalTrials.gov registry record · Phase 2
Effects of Soy Isoflavones on Menopausal Hot Flashes
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 210
- Enrollment target
NCT00179556 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 210 participants.
The verdict
NCT00179556, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 210 participants
- Enrollment target
Study Summary
Hot flashes occur in three quarters of menopausal women, and can negatively impact quality of life. Interest has arisen in isoflavones, found in rich supply in soy products, as therapy for hot flashes. The study examines the effect of a new soy supplement, as compared to a placebo, in menopausal women on hot flash symptoms.
Interventions
- DRUG Isoflavone supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2003-06 |
| Est. Completion | 2005-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179556
The ClinicalTrials.gov registry entry for NCT00179556 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Isoflavone supplement is the first listed.
NCT00179556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179556 about?
NCT00179556 is a clinical study titled "Effects of Soy Isoflavones on Menopausal Hot Flashes". Hot flashes occur in three quarters of menopausal women, and can negatively impact quality of life. Interest has arisen in isoflavones, found in rich supply in soy products, as therapy for hot flashes. The study examines the effect of a new soy supplement, as compared to a placebo, in menopausal wom...
What is the current status of trial NCT00179556?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 210 participants. The study started on 2003-06. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00179556?
The interventions under investigation include: Isoflavone supplement (DRUG).
Who is sponsoring clinical trial NCT00179556?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.